Instuitional Investor - Versant Venture Management, Llc

13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Lenz Therapeutics Inc.	LENZ	2,656,888	$123,757,843	58.25%
2.	Monte Rosa Therapeutics Inc.	GLUE	5,652,922	$41,888,152	19.72%
3.	Jade Biosciences Inc.	JBIO	1,525,820	$13,167,827	6.2%
4.	Crispr Therapeutics Ag	CRSP	148,831	$9,645,737	4.54%
5.	Skye Bioscience Inc.	SKYE	2,007,704	$7,890,277	3.71%